4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-023470
Director sold 4,000 shares at an average $73.68 ($294,736)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Connaughton Bernadette Director | 2025-09-02 | Sale 10b5-1 | −100 | $71.71 | $7,171 | 50,852 | D: show line 1 in the form |
| Connaughton Bernadette Director | 2025-09-02 | Sale 10b5-1 | −2,977 | $73.62 | $219,161 | 47,875 | D: show line 2 in the form |
| Connaughton Bernadette Director | 2025-09-02 | Sale 10b5-1 | −923 | $74.11 | $68,404 | 46,952 | D: show line 3 in the form |
| Open-market sales · 4,000 sh · avg $73.68 · $294,736 | |||||||
Loading xslF345X05/form4-09032025_120938.xml…